Kingsview Wealth Management
BTCY icon

Kingsview Wealth Management’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Kingsview Wealth Management’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,142
Closed -$433K – 1033
2021
Q4 		$433K Buy
+18,142
New +$428K 0.02% 621

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $152M AUM 26.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Beacon Pointe Advisors
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return

Kingsview Wealth Management's BTCY Position: Q1 2022 in Review

Kingsview Wealth Management sold out of Biotricity, Inc. Common Stock (BTCY) in Q1 2022, closing a stake of 18,142 shares — an estimated $433K sold.

Kingsview Wealth Management first reported a position in BTCY in Q4 2021 and held it in 1 quarter. The position peaked at $433K in Q4 2021. 32 funds tracked by Wall St. Rank hold BTCY as of Q1 2022.

  • Kingsview Wealth Management reported no remaining Biotricity, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Kingsview Wealth Management sold 18,142 Biotricity, Inc. Common Stock shares in Q1 2022, an estimated $433K.
  • Kingsview Wealth Management first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Kingsview Wealth Management's Biotricity, Inc. Common Stock position peaked at $433K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q1 2022.

Based on Kingsview Wealth Management's 13F filing for Q1 2022, filed 8 Feb 2024.